Over the last two decades, the opioid epidemic has killed more than 1 million Americans, while shifting focus from prescription painkillers to heroin to fentanyl. With each change, the crisis of addiction has become more lethal. Drug suppliers have found new ways to boost profits by making opioids more potent with cheaper drugs.

But just when you thought this public health emergency couldn’t get worse, along comes xylazine, commonly called tranq, a powerful veterinary tranquilizer used to sedate large animals but not approved for humans. Synthetic fentanyl boosts the highs derived from opioids, while tranq stretches the buzz, putting sedated users at greater risk of death, as well as of robbery and rape.

The effects of tranq are horrifying: Users experience painful, foul smelling necrotic sores; skin ulcers with oozing puss; infections and skin rots that can lead to amputations. Tranq literally eats the flesh. As this menace expands in Pennsylvania, it’s time to change the conversation on addiction.

With shifting drug markets growing more precarious and perilous, addicts and even street-level dealers often don’t know what’s in the pills or powders they’re selling, using or buying. That uncertainty makes the growing use by prosecutors of homicide-related charges in fatal drug overdoses, at best, problematic.

Advertise with us

Because tranq isn’t an opioid, it doesn’t respond to opioid-reversing medications such as naloxone, also known as Narcan, which has saved thousands of lives. But tranq is alarming for another, more obscure reason. Its acutely painful withdrawal symptoms aren’t managed by methadone, buprenorphine, naltrexone or other recovery medications used for opioid addiction. Unlike alcohol and opioids, xylazine has no established protocols for managing the misery of withdrawal.

Agony of withdrawal 

Avoiding withdrawal symptoms — not the urge to get high — is the biggest barrier to recovery. Those symptoms are excruciating, overwhelming and potentially fatal, including bone-crushing body aches, cold sweats, diarrhea, fever, skin pricks and nausea. Addicts live in terror of running out of drugs. You can see it in the face of an addicted prisoner entering a jail, knowing that a descent into hell is imminent. In a few hours, he or she may be twisting and writhing in a vomit-soiled cell.      .

To be sure, the euphoric highs, and expansive sense of well-being, that opioid users experience, especially in the early stages, are insidiously seductive: “It’s like touching the hand of God,” one heroin addict told me.

But soon, in days or weeks, users chasing those first states of bliss will need to increase doses just to feel normal and avoid gut-wrenching withdrawal symptoms, or “feigning.” That’s when the disease of addiction really kicks in, as the user becomes increasingly desperate and irrational.

Advertise with us

Why is it so hard to stop using a drug that’s destroying your life? Because addicts, enduring even the most agonizing withdrawal symptoms, know that one shot of heroin, or whatever opioid they can get, will end their suffering almost instantly.

Reducing harm 

Opponents of safe injection sites believe they encourage illicit and harmful drug use. In a rational world, that would be true, but that’s not where addiction lives. Whether addicts use the drug in a relatively safe and supervised settings, or spots that put them at great risk, doesn’t matter much. Either way, they will use. And so, probably, would you.

Tranq dominates Philadelphia’s illicit drug market, and likely will soon do the same in Pittsburgh, where it is expanding. Drug trends here tend to trail those in Philadelphia by two years.

If we care about human beings who carry the disease of addiction — and what they contribute to the community’s economic, cultural and civic life — preserving their lives and giving them a chance to recover and live productive lives must be the first priority. Pennsylvania should make newly developed test strips for tranq as available as possible, and it should participate in medical efforts nationwide to establish recovery protocols for tranq.

Advertise with us

Perhaps even more than additional treatment resources, the state needs more realistic and humane ways of thinking about drugs and addiction. Without them, the more than 5,000 fatal drug overdoses a year reported in Pennsylvania will increase dramatically, with tranq leading the latest twist in this ongoing death spiral.

Pulit­zer Prize-win­ner Jef­fery Ger­ritt is the ed­i­to­rial page ed­i­tor for the Pitts­burgh Post-Ga­zette.